MENU
+Compare
CSTL
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$34.15
Change
-$0.67 (-1.92%)
Capitalization
1.02B

CSTL Castle Biosciences Forecast, Technical & Fundamental Analysis

Castle Biosciences Inc is a molecular diagnostics company... Show more

CSTL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CSTL with price predictions
Nov 12, 2025

CSTL sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CSTL moved above the 200-day moving average on October 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on CSTL as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CSTL just turned positive on October 22, 2025. Looking at past instances where CSTL's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

CSTL moved above its 50-day moving average on October 20, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 193 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CSTL broke above its upper Bollinger Band on October 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.176) is normal, around the industry mean (12.372). P/E Ratio (30.242) is within average values for comparable stocks, (132.213). CSTL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.928). CSTL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (2.967) is also within normal values, averaging (9.791).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CSTL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CSTL is expected to report earnings to rise 2,357.50% to -49 cents per share on March 04

Castle Biosciences CSTL Stock Earnings Reports
Q4'25
Est.
$-0.49
Q3'25
Beat
by $0.50
Q2'25
Beat
by $0.66
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.31
The last earnings report on November 03 showed earnings per share of -1 cents, beating the estimate of -51 cents. With 186.36K shares outstanding, the current market capitalization sits at 1.02B.
A.I. Advisor
published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLHCX24.640.13
+0.53%
Macquarie Healthcare C
PKSCX36.040.15
+0.42%
Virtus KAR Small-Cap Core C
DALCX27.590.11
+0.40%
Dean Mid Cap Value
MFRBX54.860.03
+0.05%
MFS Research B
CYPSX61.22-0.65
-1.05%
ProFunds Consumer Disctnry Ultra Sec Svc

CSTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-0.43%
TCMD - CSTL
50%
Loosely correlated
-2.03%
GH - CSTL
38%
Loosely correlated
+0.13%
OFIX - CSTL
38%
Loosely correlated
-0.52%
NTRA - CSTL
37%
Loosely correlated
+1.34%
PACB - CSTL
36%
Loosely correlated
-6.45%
More